Brazil · Delayed Price · Currency is BRL GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of BRL 549.53 billion. The enterprise value is 647.73 billion.
| Market Cap | 549.53B |
| Enterprise Value | 647.73B |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Feb 19, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.33% |
| Float | 3.86B |
Valuation Ratios
The trailing PE ratio is 12.97 and the forward PE ratio is 10.92.
| PE Ratio | 12.97 |
| Forward PE | 10.92 |
| PS Ratio | 2.27 |
| PB Ratio | 4.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.60 |
| P/OCF Ratio | 9.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.97, with an EV/FCF ratio of 13.67.
| EV / Earnings | 15.29 |
| EV / Sales | 2.82 |
| EV / EBITDA | 7.97 |
| EV / EBIT | 9.74 |
| EV / FCF | 13.67 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.82 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 1.54 |
| Debt / FCF | 2.78 |
| Interest Coverage | 14.36 |
Financial Efficiency
Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.
| Return on Equity (ROE) | 43.31% |
| Return on Assets (ROA) | 9.79% |
| Return on Invested Capital (ROIC) | 26.53% |
| Return on Capital Employed (ROCE) | 23.78% |
| Weighted Average Cost of Capital (WACC) | 5.46% |
| Revenue Per Employee | 3.62M |
| Profits Per Employee | 633,949 |
| Employee Count | 66,841 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, GSK plc has paid 8.24 billion in taxes.
| Income Tax | 8.24B |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +19.72% in the last 52 weeks. The beta is 0.32, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +19.72% |
| 50-Day Moving Average | 55.91 |
| 200-Day Moving Average | 46.89 |
| Relative Strength Index (RSI) | 38.26 |
| Average Volume (20 Days) | 43 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of BRL 242.17 billion and earned 42.37 billion in profits. Earnings per share was 10.29.
| Revenue | 242.17B |
| Gross Profit | 175.84B |
| Operating Income | 70.03B |
| Pretax Income | 54.87B |
| Net Income | 42.37B |
| EBITDA | 84.03B |
| EBIT | 70.03B |
| Earnings Per Share (EPS) | 10.29 |
Balance Sheet
The company has 25.36 billion in cash and 131.86 billion in debt, with a net cash position of -106.50 billion.
| Cash & Cash Equivalents | 25.36B |
| Total Debt | 131.86B |
| Net Cash | -106.50B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 118.28B |
| Book Value Per Share | 30.26 |
| Working Capital | -28.77B |
Cash Flow
In the last 12 months, operating cash flow was 57.39 billion and capital expenditures -9.99 billion, giving a free cash flow of 47.39 billion.
| Operating Cash Flow | 57.39B |
| Capital Expenditures | -9.99B |
| Depreciation & Amortization | 13.38B |
| Net Borrowing | 8.97B |
| Free Cash Flow | 47.39B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.
| Gross Margin | 72.61% |
| Operating Margin | 28.92% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.50% |
| EBITDA Margin | 34.70% |
| EBIT Margin | 28.92% |
| FCF Margin | 19.57% |
Dividends & Yields
This stock pays an annual dividend of 1.83, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | 1.83 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | 7.35% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 44.86% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 3.94% |
| Earnings Yield | 7.71% |
| FCF Yield | 8.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 7 |